首页> Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research> Establishing Meaningful Change Thresholds in Patient-Reported Outcomes Among Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in ALTA-1L Trial.

Establishing Meaningful Change Thresholds in Patient-Reported Outcomes Among Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in ALTA-1L Trial.

导出原文传递

翻译打印收藏纠错

第一作者： Jennifer L,Beaumont

第一单位： Clinical Outcomes Solutions, Tucson, AZ, USA. Electronic address: jennifer.beaumont@clinoutsolutions.com.

作者： Jennifer L,Beaumont ^[1] ; Huamao M,Lin ^[2] ; Erin,Goodman ^[2] ; Hailin,Yu ^[3] ; Ashley,Geiger ^[2] ; Stacie,Hudgens ^[3]

作者单位： Clinical Outcomes Solutions, Tucson, AZ, USA. Electronic address: jennifer.beaumont@clinoutsolutions.com. ^[1] Takeda, Cambridge, MA, USA. ^[2] Clinical Outcomes Solutions, Tucson, AZ, USA. ^[3]

关键词 Anaplastic lymphoma kinase-positive non–small cell lung cancer European Organisation for Research and Treatment of Cancer QLQ-30 European Organisation for Research and Treatment of Cancer QLQ-LC13 brigatinib dyspnea scale health-related quality of life meaningful change threshold non–small cell lung cancer patient-reported outcomes

主题词人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);生活质量(Quality of Life);肺肿瘤(Lung Neoplasms);呼吸困难(Dyspnea);有机磷化合物(Organophosphorus Compounds);嘧啶类(Pyrimidines)

DOI 10.1016/j.jval.2023.10.014

PMID 37951539

发布时间 2024-04-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交